Impact of Galectins in Resistance to Anticancer Therapies

Pilar Navarro; Neus Martínez-Bosch; Ada G. Blidner; Gabriel A. Rabinovich

doi:10.1158/1078-0432.CCR-18-3870

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Reviews

Impact of Galectins in Resistance to Anticancer Therapies

Pilar Navarro, Neus Martínez-Bosch, Ada G. Blidner and Gabriel A. Rabinovich

Pilar Navarro

1Institute of Biomedical Research of Barcelona (IIBB-CSIC), Barcelona, Spain.

2Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Unidad Asociada IIBB-CSIC, Barcelona, Spain.

3Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Pilar Navarro
For correspondence: gabyrabi@gmail.com pilar.navarro@iibb.csic.es

Neus Martínez-Bosch

2Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Unidad Asociada IIBB-CSIC, Barcelona, Spain.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Neus Martínez-Bosch

Ada G. Blidner

4Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental, Ciudad de Buenos Aires, Argentina.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ada G. Blidner

Gabriel A. Rabinovich

4Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental, Ciudad de Buenos Aires, Argentina.

5Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad de Buenos Aires, Argentina.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: gabyrabi@gmail.com pilar.navarro@iibb.csic.es

DOI: 10.1158/1078-0432.CCR-18-3870 Published December 2020

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

PreviousNext

December 2020
Volume 26, Issue 23

Table of Contents
Table of Contents (PDF)
About the Cover
Editorial Board (PDF)

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Impact of Galectins in Resistance to Anticancer Therapies

Message Subject (Your Name) has forwarded a page to you from Clinical Cancer Research

Message Body (Your Name) thought you would be interested in this article in Clinical Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Impact of Galectins in Resistance to Anticancer Therapies

Pilar Navarro, Neus Martínez-Bosch, Ada G. Blidner and Gabriel A. Rabinovich

Clin Cancer Res December 1 2020 (26) (23) 6086-6101; DOI: 10.1158/1078-0432.CCR-18-3870

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Impact of Galectins in Resistance to Anticancer Therapies

Pilar Navarro, Neus Martínez-Bosch, Ada G. Blidner and Gabriel A. Rabinovich

Clin Cancer Res December 1 2020 (26) (23) 6086-6101; DOI: 10.1158/1078-0432.CCR-18-3870

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

Cited By...

Articles

Online First
Current Issue
Past Issues
CCR Focus Archive
Meeting Abstracts

Info for

Authors
Subscribers
Advertisers
Librarians

About Clinical Cancer Research

About the Journal
Editorial Board
Permissions
Submit a Manuscript

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Main menu

User menu

Search

Impact of Galectins in Resistance to Anticancer Therapies

Purchase access

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Articles

Info for

About Clinical Cancer Research